RAFの抑制後のARF6の急速な活性化は,BRAFV600Eを増加させ,治療に対する耐性を促進する
Research square
|September 5, 2025
まとめ
小さなGTPase ARF6はBRAFオンコタンパク質の発現を促進し,がん細胞の生存と薬剤耐性を促進する. ARF6を阻害することは,BRAF V600Eの癌に対する新しい治療戦略を提供することができる.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 細胞 生物学
背景:
- 癌細胞は細胞死を回避する固有の能力を持ち,腫瘍の発達,進行,転移,および耐薬性持続性 (DTP) 細胞の生存に寄与する.
- BRAF V600E オンコタンパク質は多くの癌の主要な原動力であり,そのシグナル伝達経路はがん治療の主要な標的である.
研究 の 目的:
- 小型GTPase ARF6がBRAF V600Eオンコタンパク質の発現を調節し,腫瘍生存および薬剤耐性に対する影響を調査する.
- 特にMAPK阻害剤に対する耐性の背景において,BRAF V600E誘発がんにおける治療戦略としてARF6を標的とする可能性を調査する.
主な方法:
- BRAF V600Eタンパク質レベルと腫瘍の進行に対する効果を評価するために,Arf6の腫瘍特異的な遺伝子削除を使用した.
- BRAF阻害に対するARF6の活性化と,フィードバックシグナル伝達とDTP細胞生存におけるARF6の役割を研究した.
- 耐性プロファイルが異なる患者のメラノーマ細胞におけるBRAFおよびMEK阻害剤との併用によるARF6阻害の有効性を評価した.
主要な成果:
- Arf6の腫瘍特異的消去は,BRAF V600Eタンパク質発現,MAPKシグナル伝達,および腫瘍進行を著しく減少させた.
- BRAFの阻害は迅速なARF6活性化につながり,反射回路を作り出し,抗アポプトシス信号を回復し,DTP細胞の生存と薬剤耐性を促進しました.
- 耐性メラノーマ細胞では,ARF6抑制により,BRAFとMEKを併用した標的治療に対する感受性が向上した.
結論:
- ARF6は,BRAF V600Eオンコタンパク質の合成を維持する上で重要な役割を果たし,腫瘍の生存と治療抵抗に寄与する.
- ARF6をターゲットにすることで,BRAF V600Eが誘発するがんの治療の脆弱性が示され,現在の治療法に対する耐性メカニズムを克服する可能性がある.
さらに関連する動画
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
1.2K
10:16Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
13.3K
関連する概念動画
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Small GTPases - Ras and Rho
4.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.2K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
